Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study. While a 2006 report from members of the same study team found that treatment with gonadotropin-releasing hormone agonists increased the risk of diabetes and heart disease, the current study is the first to examine whether treatment actually increased heart disease-related deaths.
- Hormone therapy for prostate cancer does not appear to increase cardiac deathsWed, 10 Dec 2008, 12:16:00 EST
- Higher risk for heart disease and diabetes associated with androgen deprivation therapyMon, 7 Dec 2009, 19:09:28 EST
- Age alone should not be used to determine whether to treat prostate cancer with hormonesWed, 24 Sep 2008, 11:31:03 EDT
- Prostate cancer patients on hormone therapy at increased risk for various heart diseasesTue, 22 Sep 2009, 5:22:31 EDT
- Being a smoker at time of prostate cancer diagnosis linked with increased risk of deathTue, 21 Jun 2011, 22:35:24 EDT